Capital Cell, a crowdfunding platform that finances new companies in the life sciences field, has received authorisation from the Financial Conduct Authority and €580,000 from seven British investors to launch the operation in London next 26 April (La Vanguardia). The company has signed a collaboration agreement with Angels in MedCity, a specialised network of 3,500 private investors from London, Oxford and Cambridge that is considered one of the biggest in Europe, and will soon present its first six investment projects in London.

Photo: Daniel Oliver, CEO of Capital Cell.